Extracellular vesicles for cancer therapy: potential, progress, and clinical challenges

Area of Science:

• Biotechnology
• Nanomedicine
• Oncology

Background:

• Extracellular vesicles (EVs) are crucial in biological processes and disease.
• Recent research highlights their potential in cancer therapy, demonstrating tumor inhibition.
• EV analogs are being developed to improve therapeutic effectiveness.

Purpose of the Study:

• To review the classification, origin, production, and purification of EVs and analogs.
• To analyze modification, drug loading, and cancer treatment applications.
• To discuss challenges and future directions for clinical translation of EV-based therapies.

Main Methods:

• Literature review of studies on EVs and their analogs for cancer therapy.
• Analysis of technologies for EV production, purification, and modification.
• Evaluation of drug loading strategies and therapeutic applications.

Main Results:

• EVs and analogs offer a platform for drug delivery in cancer treatment.
• Various methods exist for EV production, purification, and modification.
• Significant challenges remain for clinical translation, including standardization and efficacy.

Conclusions:

• EVs and their analogs hold significant potential for advancing cancer therapy.
• Further research and clinical studies are needed to overcome current limitations.
• EV-based drug delivery systems are expected to contribute substantially to future cancer treatment.